|
|
||||||||

* Department of Oncology and Surgical Sciences, University of Padova, Padova, Italy; and
Department of Molecular Pathology and Experimental Therapies, Polytechnic University of the Marche, Ancona, Italy
The CD8+ T cell response to Moloney-murine leukemia virus (M-MuLV)-induced Ags is almost entirely dominated by the exclusive expansion of lymphocytes that use preferential TCRV
chain rearrangements. In mice lacking T cells expressing these TCRV
, we demonstrate that alternative TCRV
can substitute for the lack of the dominant TCRV
in the H-2-restricted M-MuLV Ag recognition. We show that, at least for the H-2b-restricted response, the shift of TCR usage is not related to a variation of the immunodominant M-MuLV epitope recognition. After virus immunization, all the potentially M-MuLV-reactive lymphocytes are primed, but only the deletion of dominant V
rescues the alternative V
response. The mechanism of clonal T cell "immunodomination" that guides the preferential V
expansion is likely the result of a proliferative advantage of T cells expressing dominant V
, due to differences in TCR affinity and/or cosignal requirements. In this regard, a CD8 involvement is strictly required for the virus-specific cytotoxic activity of CTL expressing alternative, but not dominant, V
gene rearrangements. The ability of T cells expressing alternative TCRV
rearrangements to mediate tumor protection was evaluated by a challenge with M-MuLV tumor cells. Although T cells expressing alternative V
chains were activated and expanded, they were not able to control tumor growth in a long-lasting manner due to their incapacity of conversion and accumulation in the T central memory pool.
This article has been cited by other articles:
![]() |
P. Riedl, A. Wieland, K. Lamberth, S. Buus, F. Lemonnier, K. Reifenberg, J. Reimann, and R. Schirmbeck Elimination of Immunodominant Epitopes from Multispecific DNA-Based Vaccines Allows Induction of CD8 T Cells That Have a Striking Antiviral Potential J. Immunol., July 1, 2009; 183(1): 370 - 380. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |